Botswana vs South Africa: Prevalence rate of hypertension in adults aged 30-79
Botswana
44.1
in 2019
South Africa
44.1
in 2019
Botswana rank
35th
South Africa rank
35th
Prevalence rate of hypertension in adults aged 30-79 over time
- Botswana
- South Africa
How they compare
Botswana currently reports 44.1 against 44.1 in South Africa, a difference of 0.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Botswana ahead.
Botswana ranks 35th and South Africa ranks 35th of 194 countries.
Across the 3 decades both report, Botswana averaged higher in 2 and South Africa in 1.
Head to head by decade
| Decade | Botswana | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 40.06 | 36.51 | 3.55 | Botswana |
| 2000s | 43.29 | 42.49 | 0.8 | Botswana |
| 2010s | 44.57 | 44.97 | 0.4 | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Botswana or South Africa?
- Botswana, at 44.1 against 44.1 in South Africa as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Botswana and South Africa?
- 0, with Botswana ahead.
- How many years of comparable data are there for Botswana and South Africa?
- 30 years are reported by both, from 1990 to 2019.
- How do Botswana and South Africa rank globally for prevalence rate of hypertension in adults aged 30-79?
- Botswana ranks 35th and South Africa ranks 35th of 194 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.